Ownership history in Tidemark, LLC · 8 quarters on record
This page tracks every 13F SEC filing in which Tidemark, LLC reported a position in LIPOCINE INC (LPCN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 59 | — | 0% | 0.00% | $474 | $8.03 |
| 2025 Q3 | UNCHANGED | 59 | — | 0% | 0.00% | $168 | $2.85 |
| 2025 Q2 | UNCHANGED | 59 | — | 0% | 0.00% | $186 | $3.16 |
| 2025 Q1 | UNCHANGED | 59 | — | 0% | 0.00% | $188 | $3.18 |
| 2024 Q3 | UNCHANGED | 59 | — | 0% | 0.00% | $265 | $4.49 |
| 2024 Q2 | UNCHANGED | 59 | — | 0% | 0.00% | $486 | $8.24 |
| 2024 Q1 | UNCHANGED | 59 | — | 0% | 0.00% | $307 | $5.20 |
| 2023 Q4 | INITIATED | 59 | — | — | 0.00% | $165 | — |
As of 2025 Q4 — sorted by position size